Fluorescein-di-b-D-galactopyranoside (FDG), a fluorogenic compound, is hydrolyzed by b-galactosidase in the cytoplasm of Escherichia coli to produce a fluorescent dye, fluorescein. We found that both FDG and fluorescein were substrates of efflux pumps, and have developed a new method to evaluate efflux-inhibitory activities in E. coli using FDG and a microfluidic channel device. We used E. coli MG1655 wild-type, DacrB (DB), DtolC (DC) and DacrBDtolC (DBC) harboring plasmids carrying the mexAB-oprM (pABM) or mexXY-oprM (pXYM) genes of Pseudomonas aeruginosa. Two inhibitors, MexB-specific pyridopyrimidine (D13-9001) and non-specific Phe-Arg-b-naphthylamide (PAbN) were evaluated. The effects of inhibitors on pumps were observed using the microfluidic channel device under a fluorescence microscope. AcrAB-TolC and analogous pumps effectively prevented FDG influx in wild-type cells, resulting in no fluorescence. In contrast, DB or DC easily imported and hydrolyzed FDG to fluorescein, which was exported by residual pumps in DB. Consequently, fluorescent medium in DB and fluorescent cells of DC and DBC were observed in the microfluidic channels. D13-9001 substantially increased fluorescent cell number in DBC/pABM but not in DBC/pXYM. PAbN increased medium fluorescence in all strains, especially in the pump deletion mutants, and caused fluorescein accumulation to disappear in DC. The checkerboard method revealed that D13-9001 acts synergistically with aztreonam, ciprofloxacin, and erythromycin only against the MexAB-OprM producer (DBC/pABM), and PAbN acts synergistically, especially with erythromycin, in all strains including the pump deletion mutants. The results obtained from PAbN were similar to the results from membrane permeabilizer, polymyxin B or polymyxin B nonapeptide by concentration. The new method clarified that D13-9001 specifically inhibited MexAB-OprM in contrast to PAbN, which appeared to be a substrate of the pumps and permeabilized the membranes in E. coli.
Introduction
Increasing multidrug resistance in clinical isolates is currently a major problem in infection control. In particular, the resistance of multidrug resistant Pseudomonas aeruginosa (MDRP) to major antipseudomonal agents, such as carbapenems, quinolones, and aminoglycosides [1, 2] , has been demonstrated and is known to cause nosocomial outbreaks in Japan [3, 4] . P. aeruginosa has natural intrinsic resistance tendencies, and MDRPs have complex resistance mechanisms [5, 6] . In particular, multidrug efflux pumps, especially resistance-nodulation-cell division (RND) family pumps, can decrease the sensitivity of P. aeruginosa to various types of compounds [7, 8] . Twelve intrinsic efflux systems belonging to the RND family have been characterized from the genome sequence of P. aeruginosa [9] , and in particular MexAB-OprM, MexCD-OprJ, MexEF-OprN and MexXY efflux systems are known to have important roles in multidrug resistance [6, 10, 11, 12] . These systems can increase their resistance levels by acquiring additional resistance factors [13, 14] . During this period of new antibacterial agent scarcity, RND pump inhibitors appear useful for treating MDRP infections. The enhancing effects of an experimentally available efflux pump inhibitor, Phe-Arg-bnaphthylamide (PAbN, MC-207,110) [15] , on antibacterial activities of compounds in combination with several antibiotics have been published [12, 15, 16] , although no clinically useful inhibitor is known. Recently, 3D structures of MexB [17] and cocrystal structures of AcrB with various substrates have been resolved [18] , and some information regarding their mechanisms of efflux is available. At present, rational approaches are being employed to develop potent efflux pump inhibitors. However, no satisfactory method to determine the efflux inhibitory activities of candidate compounds directly is available.
Fluorescein-di-b-D-galactopyranoside (FDG, Figure 1 ) is a fluorogenic compound that is non-fluorescent until it is hydrolyzed by b-galactosidase in the cytoplasm of Escherichia coli to produce a highly fluorescent dye, fluorescein [19, 20, 21] . We first confirmed that both FDG and fluorescein are substrates of RND pumps in E. coli. In addition, recent progress in microfabrication technologies including soft lithography [22] has expanded their application in biology [19, 23, 24] . In this study, we constructed a simple microfluidic channel device for bacteria. By combining FDG and the microfluidic device, we developed a novel and highly sensitive method to evaluate the efflux inhibitory activities of compounds against P. aeruginosa MexB and MexY in E. coli, and clarified difference of action mechanism between two inhibitors, pyridopyrimidine (D13-9001) [25] and PAbN ( Figure 1 ). Table 1 lists all strains and plasmids used in the present study. E. coli MG1655 (wild-type), and its deletion mutants-DacrB (DB), DtolC (DC), and DacrBDtolC (DBC) [26] -were used. The vector plasmid pMMB67HE recombined with efflux pump genes mexABoprM and mexXY-oprM from P. aeruginosa [27] were kindly provided by Dr. Taiji Nakae. These plasmids were transformed with DBC to construct DBC/pMMB67HE (DBC/pV), DBC/pMMB67HE::-mexAB-oprM (DBC/pABM), and DBC/pMMB67HE::mexXY-oprM (DBC/pXYM). MDRP IMCJ2.S1 (S1) [28] was kindly provided by Dr. Kirikae. P. aeruginosa PAO1 was the standard strain.
Materials and Methods

Bacterial strains and plasmids
Antibacterial agents and chemicals
Antibacterials used were aztreonam (ATM; Sigma-Aldrich, Tokyo, Japan), ciprofloxacin (CIP; Tokyo Chemical Industry co., Ltd., Tokyo, Japan), erythromycin (ERY; Nacalai Tesque, Inc., Kyoto, Japan), and polymyxin B (PMB; MERCK KGaA, Darmstadt, Germany). D13-9001 (Daiichi Sankyo Co., Tokyo, Japan; Figure 1 ) and PAbN (Sigma-Aldrich; Figure 1 ) were used as efflux pump inhibitors. Polymyxin B nonapeptide (PMBN; SigmaAldrich) was used as an outer membrane permeabilizer. Ampicillin (AMP; Sigma-Aldrich) was added to cultures to ensure retention of the plasmid. Lactose (Sigma-Aldrich) or isopropyl-b-D-galactopyranoside (IPTG; Sigma-Aldrich) was added to the medium for bgalactosidase and plasmid-mediated pump induction. FDG (Marker Gene Technologies, Inc., Eugene, USA; Figure 1 ) and SYTOX Green (Lonza Walkersville, Inc., USA) were used for fluorometry. Nitrocefin (CalBiochem, San Diego, USA) was used as a substrate of b-lactamase in nitrocefin permeabilizing assay.
Preparation of microfluidic channels
Microfluidic channels (100 mm in width, 17 mm in height, 25-33 mm in length; Figure 2A ) fabricated in polydimethylsiloxane (PDMS; Silpot 184, Dow Corning Toray Co., Ltd., Tokyo, Japan) on a cover glass (Matsunami Glass Ind., Ltd., Osaka, Japan) were prepared as follows [22] . The pattern of each channel was designed by a software (Illustrator, Adobe Systems Incorporated, San Jose, USA), and the photomask was prepared by projecting the designed image (demagnified 610) on a 2.5-inches square glass plate (High precision photo plate PXJP, Konica-Minolta Holdings Inc., Tokyo, Japan). A photoresist (SU8-25, MicroChem, Newton, USA) was spin-coated on a silicon wafer (76 mm in diameter, Ferrotec Co., Tokyo, Japan) at 2000 rpm for 30 s and pre-baked at 65uC for 3 min and 95uC for 3 min on a hot plate (MH-180CS, AS ONE Co., Osaka, Japan). The photoresist was then covered with the photomask and exposed to UV light for 11 s using a mask aligner (ES20, Nanomeric Technology Inc., Tokyo, Japan). The photoresist was baked at 65uC for 1 min and at 95uC for 3 min, after which it was developed for 5 min, and was subsequently hard-baked at 180uC for 1 h. A patterned photoresist was spincoated with a hydrophobic polymer (0.84% CYTOP, Asahi Glass Co., Ltd., Tokyo, Japan) at 4000 rpm for 30 s, baked at 180uC for 1 h, and used as a mould for the channel. PDMS and a catalyst, mixed (10:1 by weight) and degassed under vacuum for 30 min, were put in the mould and cured at 100uC for 30 min. Polymerised PDMS peeled off the mould and the cover glass pre-cleaned with ethanol were treated with oxygen plasma using a reactive ion etching instrument (RIE-10NR, Samco, Kyoto, Japan) under appropriate conditions (Oxygen flow: 100 cc/min; Pressure: 50 Pa; RF power: 30 W) for 20 s and then bonded to each other. The inlet and outlet of the channel were then punched (BP-15F, Kai Industries Co., Ltd., Seki, Japan).
Determination of MICs and checkerboard MICs
MICs of the antibacterial agents and checkerboard MICs of these in combination with the inhibitors or the membrane permeabilizer were determined using the microdilution method defined by the Clinical and Laboratory Standards Institute (CLSI; Wayne, PA, USA). Strains harboring the plasmid were cultured in a medium containing 100 mg/ml AMP and 1 mM IPTG. The best fractional inhibitory concentration (FIC) indices were calculated as [MIC A in combination /MIC A alone +MIC B in combination /MIC B alon ] Synergy was defined as an FIC index of less than 0.5.
Efflux pump inhibition assay (FDG assay)
Effects of inhibitors on FDG and fluorescein efflux were observed in the microfluidic channel with a BZ-8000 fluorescence microscope (KEYENCE, Osaka, Japan). Overnight cultures of the strains in Luria-Bertani broth (LB; Becton Dickinson and Company, Sparks, USA) were inoculated in fresh broth and incubated on a shaker until the culture reached an OD 600 of 0.6-0.8. Lactose (50 mM) was added to induce b-galactosidase in strains harboring no plasmid. LB containing 100 mg/ml AMP and 1 mM IPTG was used to grow strains harboring the plasmid. The cultures were premixed with an inhibitor, injected in the microfluidic channels ( Figure 2A ) with 100 mg/ml FDG, and observed under a microscope after incubation for 15 min at 37uC. Multiple channels containing different samples were observed simultaneously in a single image field ( Figure 2B ). The 8-bit grayscale fluorescence ( Figure 2B , bottom) and bright-field ( Figure 2B , top) images were sequentially obtained with a cooled CCD camera. Individual cells, most of them are single, adhered to the surface and were immobile in microchannel, were identified by eye and the position of them in fluorescence image was determined manually from the bright-field image. Although it was difficult to discriminate between the intracellular and extracellular fluorescence intensity in the presence of high external fluorescein background due to the limited lateral and longitudinal resolutions of the optical microscope, we were able to correctly determine the position of the cell in the fluorescence image with this procedure. Fluorescence intensity of the individual cells and channels next to the cells were measured using ImageJ software ( Figure 2D ). The assays were carried out at least two times for individual experimental conditions, and 30-60 cells were analyzed in each experimental condition in a single assay.
Nitrocefin hydrolysis assay
The wild-type and DC strains harbouring plasmid pMMB67HE were constructed and used for the assay. The exponentially growing cultures (OD 600 0.6,0.7) of these strains in LB containing 100 mg/ml of AMP were harvested, and resuspended in AMP-free LB. Nitrocefin was added to the cell suspension to give a final concentration of 50 mg/ml, after 10 min incubation with serial concentrations of PAbN. Hydrolysis of nitrocefin was monitored in a 384-well plate with a SH-8100 microplate reader (Corona Electric Co., Ltd, Hitachinaka, Japan) at 486 nm.
SYTOX Green uptake assay
Exponentially growing (OD 600 = 0.7-1.0) wild-type, DB, and DC cells harvested in PBS containing 0.4% glucose were used. SYTOX Green is a high-affinity nucleic acid stain that easily penetrates cells with compromised membranes, but does not penetrate cells with intact membranes. Membrane integrity was determined after exposure to D13-9001, PAbN, and PMB for 20 min by measuring the uptake of SYTOX Green. Fluorescence was determined (Ex/Em: 504/523 nm) after a 10-min incubation with SYTOX Green in a black 384-well plate with the SH-8100 microplate reader.
Results
MICs of antimicrobial agents against tested strains Table 2 shows MICs of agents against strains of E. coli and P. aeruginosa used in this study. PAbN had weak antibacterial activity against these E. coli and P. aeruginosa strains, and its MIC changed by deletion or introduction of the pump genes, which revealed that pump deletion mutants had higher sensitivity to PAbN than the wild-type strain. The results indicate that PAbN is a substrate of RND pumps. D13-9001 had no antibacterial activity against these strains at concentrations less than 64 mg/ml. MIC of ATM against E. coli was not influenced by acrB and tolC deletion or pXYM introduction. However, pABM introduction decreased the sensitivity of DBC to ATM by 8-fold. In contrast, MICs of CIP and ERY against E. coli were decreased by acrB and/or tolC deletion and increased by pABM and pXYM introduction. MICs of PMB and PMBN were not influenced by deletion or introduction of these pump genes.
Combinatorial effects of inhibitors and antibacterial agents in the checkerboard method
We used three different types of antimicrobial agents to evaluate combinatorial effects of inhibitors. ATM is a substrate of MexB, although CIP and ERY are substrates of several pumps. CIP easily penetrates outer membranes of Gram-negative bacteria, but ERY hardly penetrates them [29] . Changes in MIC depending on increased concentrations of inhibitors are shown by each combination of inhibitor and antimicrobial agent. First, the effect of inhibitors on the susceptibilities of E. coli MG1655 and its pump deletion mutants, DB and DC, were compared ( Figure 3 ). D13-9001 acted synergistically with CIP and/or ERY against the wildtype strain and had no effect with either agent against DB and DC ( Figure 3A, B) . On the other hand, PAbN increased ERY activity against all strains including DB and DC ( Figure 3D ). The lowest FIC index was 0.094 for the wild-type strain and 0.188 for both mutants. In contrast, the effect of PAbN on CIP activity was only additive (FIC index = 0.75-1) against these strains ( Figure 3C ). Subsequently, the effects of inhibitors on P. aeruginosa and E. coli expressing pumps from P. aeruginosa were examined (Figure 4 ). D13-9001 acted synergistically with ATM and CIP but not with ERY, which has a higher affinity for MexY than MexB (Table 2) , against both sensitive and resistant P. aeruginosa, and the synergy between D13-9001 and ATM, which has affinity for MexB but not for MexY, was remarkable in these strains ( Figure 4A-C) . In E. coli, D13-9001 increased the susceptibilities of DBC/pABM to all three agents and had no effect on the susceptibilities of DBC/pV and DBC/pXYM ( Figure 4A-C) . The lowest FIC indices of PAbN with ATM, CIP, and ERY obtained against MDRP S1 ( Figure 4D-F) were 0.188, 0.063, and 0.05, respectively. PAbN again acted synergistically with ERY against all strains including DBC/pV. The effect of PAbN was weak on PAO1 with ATM or CIP. Furthermore, the effect of PAbN on CIP activity was not synergistic against all these E. coli strains. PAbN acted synergistically with ATM in DBC/pXYM and DBC/pV, although it was additive in DBC/pABM. Synergy between PAbN and these antimicrobial agents was not explainable by efflux pump inhibition by PAbN. Inhibitory effect of the efflux pump observed by the FDG assay
At the beginning of development of the FDG assay, we confirmed that induced activities of b-galactosidase in strains used in this study were comparable after acrB and/or tolC deletion and introduction of pumps from P. aeruginosa by a plasmid. AcrABTolC and the analogous RND pumps effectively prevented FDG influx in E. coli wild-type cells, resulting in no fluorescence ( Figure 2B, C-1) . In contrast, DB and DC easily infiltrated and hydrolyzed FDG to fluorescein, which accumulated in DC cells but not in DB cells. Consequently, we observed fluorescent medium in DB ( Figure 2B , C-2) and fluorescent cells in DC ( Figure 2B, C-3) . Images of these strains in the microfluidic channels are shown in Figure 2B . Fluorescence intensity of each cell identified in a bright-field image was determined and plotted in Figure 2D . Fluorescence distributions of the wild-type, DB, and DC strains were isolated from each other, and fluorescence was highly accumulated only in DC.
The effect of D13-9001 was not significant in wild-type E. coli in the new method ( Figure 5 ). Fluorescence in the device decreased to a minor extent by D13-9001 in a concentration-dependent manner in DB and DC, and the possibility of FDG blocking activity of D13-9001 was suggested. On the other hand, PAbN increased fluorescence in the medium of all strains, especially in DC, and accumulation of fluorescein in the cells of DC disappeared (Figure 6 ).
We also evaluated the inhibitors in relation to the MexABOprM and MexXY-OprM pumps from P. aeruginosa in E. coli. The fluorescent medium was observed in DBC carrying pABM or pXYM, while fluorescent cells were observed in DBC/pV (Figure 7 ), so these RND pumps from P. aeruginosa appeared to be working in E. coli DBC. D13-9001 clearly increased the accumulation of fluorescein in DBC/pABM cells, and fluorescent cells increased by D13-9001 in a concentration-dependent manner in DBC/pABM, although it had almost no effect on DBC/pXYM. PAbN also increased fluorescence in the medium of all these strains (data not shown).
Characterization of PAbN activity on membrane in comparison with an outer membrane permeabilizer PMBN
By the new method, PAbN seemed to have membrane peameabilizing activity. Separately from efflux pump inhibitor, even old, outer membrane permeabilizer has been approached to enhance activity of antimicrobial agents [30, 31, 32, 33] . Among them, PMBN is known to peameabilize outer membrane but inner membrane of Gram-negative bacteria, although PMB peameabilizes both membranes [34, 35, 36] . We determined activity of PMBN in combination with CIP or ERY (Figure 8 ). Effect of PMBN on CIP activity was additive against the E. coli strains and PAO1, and was synergistic against S1. In contrast, PMBN increased ERY activity against all strains including DB, DC and DBC/pV. These results obtained from PMBN were comparable with the results from PAbN. Effect of PMB on ERY was additive against all strains tested (Data not shown).
We further evaluated membrane peameabilizing activity of PAbN with PMB and PMBN in DC by the new device method ( Figure 6, Figure 9 ). Fluorescein accumulation in DC cells was disappeared by 4 mg/ml of PAbN as well as by PMBN. PMB increased fluorescence of medium in more than 1 mg/ml, and fluorescein accumulation was still seen in 1 mg/ml of PMB. MexB inhibitor D13-9001 had almost no effect on fluorescein distribution in DC ( Figure 5 ). Disappeared accumulation of fluorescein in DC cells and increased fluorescence in the medium of DC would correspond with peameabilizing of outer membrane and inner membrane of E. coli, respectively. The effect of PAbN was similar with PMBN in lower concentrations, and was similar with PMB in higher concentrations ( Figure 6 ). Effect of outer membrane permeabilizer is significant with antibacterial agents that are effectively excluded by the intact outer membrane. Synergistic action of PAbN in combination with ERY seemed come from its outer membrane peameabilizing activity.
Outer Membrane permeabilization determined by nitrocefin hydrolysis assay
Nitrocefin, a chromogenic b-lactam is easily hydrolyzed by periplasmic b-lactamase of cells having permeabilized outer membrane, so that its increased rate of hydrolysis in intact cells has been used for an indicator of increased outer membrane permeation of nitrocefin [37] . We used both wild-type and DC strains harbouring plasmid pMMB67HE for the nitrocefin assay, because nitrocefin is also known as a substrate of AcrB [38] ( Figure 10 ). Ten minutes incubation with PAbN in the concentration higher than 4 mg/ml increased nitrocefin hydrolysis in the both strains. Activity of efflux pumps in the wild-type strain had almost no effect on nitrocefin assay, although MexAB-OprM overproduction in P. aeruginosa diminished the effect of PAbN on nitrocefin hydrolysis in the literature of Lomovskaya et al. [15] . The results show stronger activity of PAbN on outer membrane of E. coli than on that of P. aeruginosa published in the past [15] . Outer membrane permeabilizing activity of PAbN in this nitrocefin hydrolysis assay was harmonized with the activity obtained from the FDG assay.
Inner Membrane permeabilization determined by SYTOX Green uptake assay SYTOX Green, a DNA intercalater, barely penetrates membranes of intact cells. In the three E. coli strains tested, determined fluorescence was slightly higher in pump deletion mutants than in the wild-type strain (Figure 11 ). The membrane permeabilizer PMB increased SYTOX Green uptake in all strains, regardless of efflux pump activity. PAbN increased SYTOX Green uptake in these strains, although its effect was moderate in the wild-type cells and remarkable in the DB and DC cells. MICs of PAbN (Table 2 ) correlated with its inner membrane-damaging activity obtained in Figure 11 , which appeared to be the mechanism of its antibacterial action. D13-9001 slightly decreased SYTOX Green uptake in all of the strains as well as the results obtained from FDG uptake in the new method.
Discussion
Several fluorometric methods evaluating efflux pump inhibitors have been published using substrates of these pumps such as alanine b-naphthylamide [15] , N-phenylnaphthylamine [15] , ethidium bromide [15] , and pyronin Y [39] . Lomovskaya et al. used a related compound MC-002,595 instead of PAbN in the methods using alanine b-naphthylamide or N-phenylnaphthylamine. They could not determine inhibitory activities of PAbN itself by these methods due to the high background fluorescence [15] . Furthermore, PAbN has been reported to have no inhibitory effect on efflux of ethidium bromide [15, 40, 41] , which is also known as a substrate of ABC-type transporter [42] . What is more, fluorescence of these compounds was not as strong as that of fluorescein, and thus they are not considered to be suitable for the assay in the microfluidic channel. The role of efflux pumps on FDG hydrolysis in E. coli was not fully understood when we chose FDG as a substrate for the assay at the beginning of this study. FDG was defined as a substrate of RND pumps because it was easily hydrolyzed in pump deletion mutants compared with wild-type cells (Figure 2 ). If FDG was not a substrate of pumps, it will be difficult to discriminate DB from wild-type. Fluorescein was also defined as a substrate of pumps from its accumulation in DC cells. Furthermore, from the results of complete blockage of FDG hydrolysis by protonophore CCCP addition in all of the strains including DC (data not shown), FDG was defined to be actively imported into the cytoplasm. The lactose permease LacY is not a FDG permease because lacY deletion from DlacI mutants (constitutive b-galactosidase producer) had no effect on FDG hydrolysis in the mutants (data not shown), and we have yet to identify a FDG permease. Figure 12 shows the proposed mechanism of FDG hydrolysis in E. coli. In wild-type cells, FDG is hardly imported into cytoplasm because FDG is exported by AcrB from periplasm before it is trapped by permease. Rate of FDG influx will increase depending on a concentration of FDG in periplasm until it reach maximum rate. Moderate inhibition of the pumps causes FDG influx and an efflux of fluorescein from the cells by the remaining activity of the pumps, and full inhibition of (Figure 2) . A real pump inhibitor without any effect on bacterial membrane will increase fluorescence in wild-type cell by concentration dependent manner and will cause increased accumulation of fluorescence in the cells. In fact, we detected moderately increasing fluorescence and increased accumulation of fluorescence in DBC/pABM according to increasing concentration of D13-9001 ( Figure 6 ). In contrast, peameabilization of outer membrane will cause leakage of fluorescein from DC cells, and peameabilization of inner membrane will efficiently increase FDG influx and fluorescein production to release it from cells with or without pumps. By the FDG assay, it is easy to detect outer membrane peameabilization by disappearance of fluorescein accumulation in DC cells, and inner membrane peameabilization by increased fluorescence especially in the medium of pump deletion mutants. Determination of efflux pump inhibition activity via the typical methods of measuring the influx or efflux of some substrates by their fluorescence with a plate reader makes it difficult to exclude the effect of outer membrane peameabilizing activity. In addition, accurate estimation of FDG hydrolysis through monitoring fluorescence with a plate-reader is impractical because the total fluorescence of fluorescein is higher when diffused in the medium than when accumulated in the cells, and fluorescence determined by a plate reader was usually higher in DB than in DC. Therefore, fluorescence determined by a plate reader does not accurately correlate with the amount of fluorescein produced, and it is difficult to estimate the inhibitory effect on pumps with FDG by a plate reader. The microfluidic channel method enables discrimination of pure efflux pump inhibition from membrane permeabilization. However, when more than two different pumps are present in a cell, it may be difficult to detect the effect of a specific inhibitor on either of them. To overcome this problem, we need a mutant deleting all RND pumps and sustaining TolC in which fluorescein is accumulated. Deletions of acrB, acrD, acrEF, mdtABC, and mdtEF were not sufficient to ensure accumulation of fluorescein in a manner similar to that in DC (data not shown).
D13-9001 is known to specifically inhibit the MexAB-OprM pump [25] . In the microfluidic channel method, D13-9001 clearly inhibited the MexAB-OprM pump but did not inhibit the MexXY-OprM pump (Figure 7) . The effect of D13-9001 on AcrAB-TolC of E. coli would be detected by this method when a strain producing only AcrAB-TolC is available. Combinatorial effects of D13-9001 with the antimicrobials assessed by the checkerboard method are easily understandable by the inhibition of the AcrB or MexB pump in all the tested strains of E. coli and P. aeruginosa. The synergy of D13-9001 was determined to be the strongest with ATM, which is a substrate of MexB and not of other pumps.
Throughout this study, we could not definitively answer the question as to whether PAbN really acts on efflux pumps. We observed that PAbN increased FDG hydrolysis and leakage of fluorescein in all strains, especially in pump deletion mutants, by this new method ( Figure 6 ). Since PAbN was first reported, it has been universally recognized as an efflux pump inhibitor [12, 15] , and the effect of PAbN on MDRP S1 was remarkably synergistic with all the agents examined in this study (Figure 4) . However, PAbN increased the susceptibilities of pump deletion mutants of E. coli especially to ERY, although it had almost no effect on CIP against E. coli expressing MexAB-OprM or MexXY-OprM ( Figure 4E ), which means PAbN could not inhibit efflux of CIP by MexB or MexY. PAbN also increased susceptibility of E. coli expressing MexXY-OprM to ATM, which is not a substrate of MexXY-OprM ( Figure 4D ). These actions of PAbN do not correlate with efflux pumps, and are similar to those of outer membrane permeabilizer PMBN. The effect of PAbN on the outer membrane was already known when it was discovered [15] . They used nitrocefin hydrolysis assay by intact cells to evaluate outer membrane permeabilizing activity of PAbN in P. aeruginosa, and permeabilizing activity was visible in lower than 16 mg/ml on outer membrane of a pump deficient strain or a CCCP applied strain. Nitrocefin is a substrate of efflux pumps [38] , so that permeabilizing activity should be evaluated in pump deficient condition. Permeabilizing activity of PAbN on outer membrane of E. coli by the assay using nitrocefin (Figure 10 ) was comparable to the activity obtained from the FDG assay and was higher than that on outer membrane of P. aeruginosa [15] . Outer membrane permeabilizing activity of PAbN have also been published by other researchers using resazurin as a substrate [43] . In our FDG assay, the effect of PAbN on the outer membrane of E. coli was visible in 4 mg/ml ( Figure 6 ). LB was used for the FDG assay and the results would be easy to compare with the results of synergy in MICs with antimicrobial agents. LB used in our study contains 0.24 mM Mg 2+ (information from the manufacturer). When additional 1 mM Mg 2+ was added to LB, effect of PAbN on outer membrane decreased to some extent although it was not disappeared in the FDG assay (data not shown), and accordingly, addition of Mg 2+ to the medium also decreased synergistic activity of PAbN with ERY to P. aeruginosa PAO1 (data not shown). Outer membrane permeabilizing activity is known to increase the sensitivity of bacteria to antimicrobial agents like ERY which excluded by the intact outer membrane [32, 44] as well as efflux pump inhibition, and we could get similar results by PMBN. The effect of PAbN on antimicrobial agents (Figure 3-4) seems to be explainable with its activity on membranes of E. coli. We could not obtain any clear evidence of the inhibitory activity of PAbN on the efflux pump itself. Although competitive inhibition of efflux pumps by another substrate was not proved in E. coli by Elkins, et al. [45] , the possibility that PAbN competes with a substrate for binding to the efflux pump cannot be excluded completely. Precise mechanism of synergy between PAbN and antimicrobial agents should be elucidated elsewhere.
Nevertheless, susceptibility-augmenting agents such as PAbN may be useful in combination with a substrate of multi efflux pumps such as ERY and CIP because it will be difficult to develop a super inhibitor that can inhibit all pumps including those with different structures. The effect of D13-9001 is simple and specific to strains expressing AcrB or MexB pumps, and D13-9001 shows the most synergistic effect with ATM, which is the substrate preferred by MexB and no other pumps. From this new method, it is concluded that D13-9001 specifically inhibits MexB, in contrast to PAbN, which appeared to be a substrate of the pumps and permeabilized the membranes of E. coli.
